Clinical decision support

Guidelines & calculators

Practice guidelines and risk calculators

Third-party guidelines and prediction tools relevant to perianal Crohn’s disease, each independently verified against PubMed. These are external documents and tools — linked, not reproduced, and not evidence-gated by this site.

Read the access and validation labels. Very few published IBD prediction tools are simultaneously a live free calculator, externally validated, and validated for the decision you are about to make. Where a tool is formula-only, or was validated only in its derivation cohort, that is stated rather than hidden behind a link. 6 further item(s) found by this review are withheld pending clinician sign-off rather than published unverified.

Practice guidelines

ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment ECCO (European Crohn's and Colitis Organisation) · 2024 · PMID 38878002 · J Crohns Colitis
The single most on-scope surgical document: graded statements on seton placement/removal, fistulotomy, endorectal advancement flap (Statement 3.11, complex fistula without proctitis), LIFT, mesenchymal stem cells/darvadstrocel, faecal diversion and proctectomy, plus preoperative optimisation.
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment ECCO (European Crohn's and Colitis Organisation) · 2024 · PMID 38877997 · J Crohns Colitis
Companion document to the surgical guideline; supplies the drug side of combined medical-surgical therapy for complex perianal fistulae (infliximab induction/maintenance and positioning of newer agents).
ACG Clinical Guideline: Management of Crohn's Disease in Adults ACG (American College of Gastroenterology) · 2025 · PMID 40701562 · Am J Gastroenterol
GRADE-based US medical guideline covering the fistulising phenotype; the current ACG reference for drug selection in perianal fistulising CD. Replaces the 2018 Lichtenstein edition.
British Society of Gastroenterology guidelines on inflammatory bowel disease in adults: 2025 BSG (British Society of Gastroenterology) · 2025 · PMID 40550582 · Gut
Comprehensive 101-page UK IBD guideline (Gut 2025;74[Suppl 1]:s1-s101) including perianal fistulising CD; supersedes the 2019 BSG consensus guidelines.
AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease AGA (American Gastroenterological Association) · 2021 · PMID 34051983 · Gastroenterology
Still the operative AGA guidance for perianal fistulising CD (infliximab recommended; adalimumab/ustekinumab/vedolizumab suggested). Its LUMINAL recommendations are superseded by the 2025 AGA living guideline, which explicitly excludes perianal CD from its scope.
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Management of Anorectal Abscess, Fistula-in-Ano, and Rectovaginal Fistula ASCRS (American Society of Colon and Rectal Surgeons) · 2022 · PMID 35732009 · Dis Colon Rectum
The ASCRS document that most directly addresses anorectal Crohn's: drainage, seton use, sphincter-sparing repair (LIFT, flap), rectovaginal fistula, and when imaging is indicated in Crohn's fistula.
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's Disease ASCRS (American Society of Colon and Rectal Surgeons) · 2020 · PMID 32692069 · Dis Colon Rectum
Current ASCRS surgical guideline for CD, including perianal disease, diversion and proctectomy. Note: ASCRS revises on roughly a 5-year cycle, so this one is past due for update — check for a revision before quoting it as current.
Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials TOpClass Consortium (international multidisciplinary expert consensus; not a society guideline) · 2022 · PMID 35325623 · Lancet Gastroenterol Hepatol
The primary TOpClass classification paper: four classes stratified by severity, outcome and patient goal, replacing the simple/complex dichotomy. This is the classification to build the page's decision tree on.
Defining Radiological Healing in Perianal Fistulizing Crohn's Disease: A TOpClass Global Expert Delphi Consensus TOpClass Consortium (Delphi consensus, 84 international experts) · 2026 · PMID 40210078 · Clin Gastroenterol Hepatol
Answers 'when is this fistula actually healed on MRI?' — the question that governs seton removal, timing of a closure attempt (LIFT/flap), and therapy de-escalation. Clin Gastroenterol Hepatol 2026;24:190-200.
Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus TOpClass Consortium (Delphi consensus) · 2025 · PMID 38871152 · Clin Gastroenterol Hepatol
Six consensus statements on screening, risk assessment and management of malignancy arising in long-standing perianal fistulising CD — directly relevant to the threshold for proctectomy. Authors note overall quality of evidence was low.
Isolated perianal Crohn's disease: a systematic review and expert consensus proposing novel diagnostic criteria and management advice International expert consensus (Lancet Gastroenterol Hepatol) · 2025 · PMID 40315877 · Lancet Gastroenterol Hepatol
Framework for the commonest upstream decision on this page: is this perianal Crohn's (needs IBD therapy) or idiopathic/cryptoglandular fistula (primarily surgical), when luminal inflammation is absent. Lancet Gastroenterol Hepatol 2025;10:757-768.

Risk calculators and prediction tools

MRI-based prediction model for anti-TNF treatment failure in perianal Crohn's disease formula only — no calculatorderivation cohort onlyEstimates the probability of clinical anti-TNF failure at 6 months in biologic-naive adults starting their first anti-TNF for perianal fistula — i.e. helps decide whether to plan combined medical-surgical therapy up front. · PMID 38122958 Note: INTERNALLY VALIDATED ONLY, in the derivation cohort (n=221, retrospective, multicentre 2005-2022). Discrimination is only fair — concordance statistic 0.67 (full) and 0.65 (simplified MRI-only) — so it should inform discussion, not gate a decision. No external validation and no published web calculator; the model must be applied from the article. Requires central-quality MRI re-read, which most centres will not replicate.
3D transrectal ultrasound nomogram for early biologic treatment failure in perianal fistulising Crohn's disease formula only — no calculatorderivation cohort onlyPredicts early failure of biologic therapy (stable or aggravated disease on MRI at ~12 weeks) from pre-treatment 3D-TRUS parameters. · PMID 42024671 Note: TREAT WITH STRONG SCEPTICISM. Reported training AUC of 0.955 from only 3 predictors in 80 patients is implausibly high and almost certainly optimistic; the 'external' validation cohort is a single second hospital with just 22 patients, which cannot meaningfully confirm calibration. Retrospective, two-centre, and 3D-TRUS is not widely available or standardised. Not ready for individual patient decisions.

Also on MDCalc

These are established instruments already hosted as free, working calculators by MDCalc. We link them rather than rebuild them — our own decision-support tools above cover what MDCalc does not, and every link below was verified against MDCalc directly.

Montreal Classification for IBD live calculatorclassificationAssigns Montreal extent (E1-E3) and severity (S0-S3) for UC, and age / location / behaviour (A, L, B) for Crohn's. Note: A PHENOTYPE classification, not a prediction model. Extent should be recorded as the maximum ever documented, not the most recent endoscopic appearance, which underestimates true extent in quiescent disease.
Crohn's Disease Activity Index (CDAI) live calculatoractivity indexThe historical primary endpoint in Crohn's trials; requires a 7-day patient diary plus labs. Note: Correlates POORLY with endoscopic inflammation — a normal CDAI does not exclude active disease. Explicitly invalid in stricturing/fistulising disease, after extensive resection, and in patients with a stoma. Pair with CRP/faecal calprotectin and imaging.
Harvey-Bradshaw Index (HBI) for Crohn's Disease live calculatoractivity indexThe single-day simplified CDAI used in clinic; remission conventionally <5. Note: Symptom-driven, so it shares CDAI's blindness to endoscopic activity. The severity bands are from the literature, not from MDCalc's page.
Simplified Endoscopic Activity Score for Crohn's Disease (SES-CD) live calculatorendoscopicEndoscopic activity in Crohn's: ulcer size, ulcerated and affected surface, and stenosis across five segments. Note: Requires full ileocolonoscopy with all five segments assessed; a partial exam is not scoreable. Objective counterpart to the symptom-based CDAI/HBI.

Guideline summaries hosted by MDCalc:

ACG Clinical Guideline: Management of Crohn's Disease in Adults (via MDCalc) guidelineMDCalc's structured rendering of the ACG Crohn's guideline. Note: Check the publication date against the current ACG listing before presenting it as current.
ACG: Preventive Care in Inflammatory Bowel Disease (via MDCalc) guidelineVaccination, bone health, skin-cancer and cervical-screening recommendations for immunosuppressed IBD patients. Note: Directly relevant before starting biologics or immunomodulators, and a frequent gap in surgical clinics.